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Anti-HLA Antibodies Complicating Infectious Mononucleosis
with Thrombocytopenia and Neutropenia
Warren L. Kupin, MD,* and Maria Sawdyk, MD^

A case concerning a 21-year-old male college student with thrombocytopenia and neutropenia
complicating infectious mononucleosis is presented. Although the patient had no prior history of
alloimmunization, a broad spectrum anti-HLA antibody was strongly positive in his serum.
Concomitant with resolution ofthe hematologic abnormalities, the titer ofthe antibody diminished.
This case is unique both in the severity ofthe thrombocytopenia and neutropenia andfor the
circulating HLA antibody most likely of viral origin. (Henry FordHosp Med J 1986;34:65-7)

I

nfectious mononucleosis has been associated with a wide variety of hematologic manifestations, of which the production
of a marked atypical lymphocytosis is most characteristic. Mild
subclinical thrombocytopenia (60/mm^ to 140,000/mm') and
neuttopenia (1,0001mm^ to l,800/mm3) have been found to occur in upwards of 24% to 50% of the cases (1,2). Severe thrombocytopenic purpura (20,000/mm3) and an absolute neutropenia (750/mm3) are each considered to be extremely rare
manifestations of infectious mononucleosis and occur in less
than 1% and 2% of the cases, respectively (3,4). Recent smdies
strongly implicate an autoimmune basis for the severe thrombocytopenia, while no one explanation has yet been accepted for
the absolute neutropenia (5). We report a case of infectious
mononucleosis combining both of these uncommon hematologic disorders associated with the presence of a broad spectmm circulating anti-HLA antibody.

positive for an IgM cold agglutinin of anti-i and anti-I specificity. Immune electrophoresis revealed diffuse mild hypergammaglobulinemia.
Urinalysis showed 5 to 10 RBC/HPF.
Bone marrow examination on the day of admission revealed megakaryocyte hyperplasia with mild granulocyte hyperplasia. Subsequent
monospot test was positive; cold agglutinin titer was 1:32; and heterophile antibody titer was 896 before absorption with guinea pig kidney
cells, 448 afterward, and 28 after absorption of beef cells. Epstein-Barr
vims titer was 10,240 initially and 2,560 after two months.
The pafient was started on 60 mg/d of prednisone the evening of admission. The course of the platelet and WBC levels are depicted in the
Figure. Mild bloody dianhea developed on the seventh day, but all
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Case Report
A previously healthy 21-year-old male college smdent, referred from
an outside hospital, complained of spontaneous bleeding from his gums
and easy bruising over a two-day period. He had been well until fliree
weeks prior to his presentation when he developed a sore throat, lowgrade fever, and tender cervical adenopathy. Subsequently, he had experienced persistent malaise and anorexia resulting in a weight loss of
15 pounds. He was not on any medications, had no toxin exposure, and
no concurrent medical problems.
Physical examination revealed a thin but muscular male in no acute
disfress. Vital signs were normal. Multiple purpuric lesions were noted
on his thighs and buttocks with petechiae over the dorsum of his feet
and on his shoulders, Hemonhagic bullae were noted on the buccal
mucosa and palatine petechiae were present. Diffuse nontender adenopathy was palpable. Splenomegaly was measured to 11 cm by percussion. Stool wasttaceHemoccult positive.
Laboratory data revealed a white cell count of 8,000/mm' with 4%
mature neuttophils, 4% bands, and 46% atypical lymphocytes. The initial platelet count was 4,000/mm' but fell to a low of 2,000/mm' during
hospitalization. Hemoglobin was 12.6 g/100 mL with a reticulocyte
count of 1.5%. Westergreen sedimentation rate was 10 mmlh. Liver
function tests revealed mildttansaminaseelevation. Coombs' test was
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Figure—The patient's platelet (•—•) and neutrophil
counts during hospitalization and after discharge.
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bleeding manifestations stopped by the next day, and the patient was
discharged on the tenth day with a slowly tapering dose of prednisone.
At one- and two-month follow-up he was off all steroids and doing well
with a normal platelet count.
An antiplatelet antibody test (method of Lizak and Gmmet [6]) on
admission was negative in the complement mediated cytotoxicity assay,
but the patient's semm was strongly positive for anti-HLA antibodies.
Two months later his anti-HLA antibody was still present but in lower
titer (measured by percent kill of lymphocytes), with 100% cell kill on
admission decreasing to 50% to 60% cell death at thefimeof follow-up.

Discussion
We have reviewed the 53 cases of thrombocytopenic purpura
secondary to infectious mononucleosis that have been reported
thus far in the English literature. In addition to our own case,
only 12 well-documented cases of thrombocytopenia of less than
5,000/mm' have been reported (5,7-12). In light of the frequent
finding of megakaryocyte hyperplasia (72% of the cases) in
these thrombocytopenic patients, an autoimmune mechanism
has long been postulated (13).
Numerous techniques have been successfully and unsuccessfully employed to determine the existence of an antiplatelet
antibody. In 1972, Ellman showed the presence of a plateletbound IgG antibody utilizing a C'^-serotonin release assay,
which has been recently confirmed (5,14). The mechanism of
platelet destruction has been compared to that in idiopathic
thrombocytopenic purpura involving predominantiy splenic reticuloendothelial removal of antibody-coated platelets without
complement activation. No specific platelet antigen has yet been
implicated as a site for antibody binding.
Mild absolute neutropenia (2,865/mm') in the first three to
four weeks of illness was noted by Cantow (2) in 80% of the
cases. Absolute counts were rarely below 1,000 and occuned
without clinical sequela. Recently, however, Hammond reviewed 11 cases of severe neuttopenia (200/mm') reported in the
literature and found two episodes of related sepsis, one due to
Staphylococcus aureus and one secondary to Hemophilus influenza and Staphylococcus aureus (15).
Bone manow examinations in these patients with severe neutropenia revealed four cases of myeloid hyperplasia and seven
cases of "maturation anest" at the promyelocyte level. A further review of nine prospective cases of mild neutropenia revealed myeloid hyperplasia in all patients (13). Megakaryocyte
cell lines were normal, and no case involved concomitant
thrombocytopenia.
Leukoagglutinating activity has been noted in the sera of patients with infectious mononucleosis, and circulating antineutrophil IgG antibody has been recentiy demonstrated (4,16).
Consequently, the pathogenesis of neutropenia, in conjunction
with thrombocytopenia in infectious mononucleosis, appears to
be clearly linked to an autoimmune mechanism.
Combined autoimmune thrombocytopenia and neutropenia
have been found in different clinical settings: systemic lupus
erythematosus, idiopathic Felly's syndrome, and immune hemolytic anemia (17). Platelet antibodies have been defined with
varying antigenic specificities including anti-ABO, anti-PF',
anti-HLA, and dmg related and ITP related antibodies. Our patient exhibited severe thrombocytopenia (2,000/mm') and neutropenia (640/mm') associated with active Epstein-Ban vims
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infection that resolved over a two-week period with prednisone
therapy. An HLA-antibody was detected both during the acute
disease and two months later during convalescence in decreasing titer.
Specific HLA typing of the antibody was unsuccessful because lymphocytoxicity occuned in all wells of the tissue-typing tray. This illustrates the unique broad spectmm of this HLA
antibody in an individual with no prior history ofttansfusionsof
blood or blood products. In the absence of alloimmunization,
we can only speculate as to its etiology in our patient.
The specificity of this antibody must be directed against class
I HLA antigens of the A, B, and C systems since platelets have
not been shown to express class II antigens of the HLA-D locus.
Antigenicity is genetically determined on chromosome #6 and
expressed by the heavy chain of the HLA complex, while the Bj
microglobulin glycoprotein is coded for separately on chromosome #15. Due to the broad specificity of this antibody, involvement of the ubiquitous Bj microglobulin component seems
most likely. To fulfill this hypothesis, the Epstein-Ban virus,
through its binding to specific E-B vims receptors known to be
present on B lymphocytes, must alter the HLA complex. Indeed, a physical link between the receptor for E-B vims and a
major histocompatibility complex glycoprotein has been demonstrated, and the cytotoxic T-cell response to this viral infection has been shown to be dependent on the presence of the HLA
complex (18,19).
Our patient's antiplatelet cytotoxicity assay was repeatedly
negative, which indicates that platelet destmction in this patient
was not mediated by antibody-induced complement activation.
This is compatible with a recent report indicating that IgG-mediated erythrocyte autoimmunity involves removal by the reticuloendothelial system through F^ component recognition,
while IgM-mediated antibodies tend to predominantly activate
complement (20), Lizak and Gmmet, however, were able to detect HLA antibodies against platelets with their procedure although we were unable to do so in our case. We feel that the
distribution of the IgG antibody on the surface of the platelet
may not have been dense enough to activate complement deposition. Removal of these IgG-coated platelets would then occur
through F^ recognition by specific receptors in the reticuloendothelial system without the requttement for complement. This
HLA antibody does not appear to be sjiecific for vims-infected B
lymphocytes, as it was detectable in tissue typing with cells of
healthy adults. Unfortunately, the patient was not available for
further testing using autologous cells after resolution of the
leukopenia.
A number of "immunologic epiphenomena" occur with
infectious mononucleosis including the production of anti-I,
antinuclear antibodies, and rheumatoid factor Consequently,
anti-HLA antibodies may represent another as yet unrecognized
immunologic reaction to this viral infection. Evidence for the
clinical significance of these antibodies in the genesis of the varied manifestations of this disorder is not yet clear.
In summary, we have presented a case of infectious mononucleosis complicated by severe thrombocytopenia and neuttopenia. The presence of a unique broad spectmm HLA antibody that decreased in titer over time lends support to its role in
this disorder. This is the first description of a specific antigen
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that may be involved in the pathogenesis of this autoimmune
reaction.
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